Literature DB >> 30816573

miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer.

Gang Li1, Kai Wang2, Jiansheng Wang1, Sida Qin1, Xin Sun1, Hong Ren1.   

Abstract

MicroRNAs plays an important role in the ccurrence and development of non-small-cell lung cancer (NSCLC). miR-497-5p has been reported to function as a tumor suppressor in various cancers. However, the role of miR-497-5p in NSCLC remains poorly understood. In this study, we aimed to investigate the biological role and potential molecular mechanism of miR-497-5p in NSCLC. Our results showed that the messenger RNA (mRNA) expression level of miR-497-5p was notably downregulated in human NSCLC tissues and cell lines. miR-497-5p overexpression remarkably inhibited NSCLC cell proliferation and increased cell apoptosis in A549 and H460 cells, whereas inhibition of miR-497-5p had an opposite effect. The ability of cell migration and invasion was inhibited by miR-497-5p overexpression but was increased by miR-497-5p inhibition. Moreover, our findings indicated that SOX5 was a direct target of miR-497-5p. The protein and mRNA expression levels of SOX5 in A549 cells were remarkably inhibited by miR-497-5p overexpression but was upregulated by miR-497-5p inhibition. Furthermore, SOX5 overexpression notably reversed the effect of miR-497-5p mimic on NSCLC cell proliferation, cell apoptosis, cell migration, and invasion. Taken together, these results indicated that miR-497-5p overexpression inhibited NSCLC cell proliferation, migration and invasion, and induced cell apoptosis through inhibiting SOX5 gene expression. It was conceivable that miR-497-5p might serve as a potential molecular target for NSCLC treatment.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  SOX5; cell growth; cell invasion; miR-497-5p; non-small-cell lung cancer

Year:  2019        PMID: 30816573     DOI: 10.1002/jcb.28345

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  21 in total

1.  LncRNA UCC promotes epithelial-mesenchymal transition via the miR-143-3p/SOX5 axis in non-small-cell lung cancer.

Authors:  Ri Chen; Chunfan Zhang; Yuanda Cheng; Shaoqiang Wang; Hang Lin; Heng Zhang
Journal:  Lab Invest       Date:  2021-04-06       Impact factor: 5.662

2.  Suppression of CX3CL1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells.

Authors:  Wen Tang; Ping Jia; Lin Zuo; Jia Zhao
Journal:  Cell Cycle       Date:  2022-04-29       Impact factor: 5.173

3.  MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients.

Authors:  Lin-Lin Tian; Bin Qian; Xiao-Hui Jiang; Yu-Shan Liu; Tong Chen; Cheng-You Jia; Ya-Li Zhou; Ji-Bin Liu; Yu-Shui Ma; Da Fu; Sen-Tai Ding
Journal:  Int J Genomics       Date:  2021-03-16       Impact factor: 2.326

4.  MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer.

Authors:  Tong Li; Wenjuan Zhou; Yimin Li; Yaqi Gan; Yulong Peng; Qing Xiao; Chunli Ouyang; Anqi Wu; Sai Zhang; Jiaqi Liu; Lili Fan; Duo Han; Yu Wei; Guang Shu; Gang Yin
Journal:  PLoS One       Date:  2019-04-02       Impact factor: 3.240

5.  miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3.

Authors:  Lan Feng; Kai Cheng; Rongjia Zang; Qingdong Wang; Jianjie Wang
Journal:  Biosci Rep       Date:  2019-09-06       Impact factor: 3.840

6.  Up-regulation of microRNA-497-5p inhibits colorectal cancer cell proliferation and invasion via targeting PTPN3.

Authors:  Sen Hong; Zhenkun Yan; Helei Wang; Lei Ding; Miaomiao Bi
Journal:  Biosci Rep       Date:  2019-08-13       Impact factor: 3.840

7.  CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.

Authors:  Yaming Li; Jinzhao Zhang; Shuang Pan; Jing Zhou; Xin Diao; Song Liu
Journal:  Thorac Cancer       Date:  2020-01-09       Impact factor: 3.500

8.  High expression levels and localization of Sox5 in dilated cardiomyopathy.

Authors:  Yafeng Liu; Ben Jiang; Yide Cao; Wen Chen; Li Yin; Yueyue Xu; Zhibing Qiu
Journal:  Mol Med Rep       Date:  2020-05-22       Impact factor: 2.952

9.  Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer.

Authors:  Jing-Jing Zheng; Qiao-Yan Que; Hong-Tao Xu; de-Sheng Luo; Zheng Sun; Jun-Sheng Ni; Hai-Feng Que; Ji Ma; Dan Wu; Hua Shi
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer.

Authors:  Sen Hong; Zhenkun Yan; YuMei Song; MiaoMiao Bi; Shiquan Li
Journal:  Aging (Albany NY)       Date:  2020-03-23       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.